Glycans in Vaccine Development

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Screening and drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycans in Vaccine Development

September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 16-17, 2017

3rd Annual Congress on Bioscience

Dubai,UAE
October 18-19, 2017

10th Annual Chemistry Congress

Osaka, Japan
October 30 - 31, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

Glycobiology Biochem Conference 2018

Paris, France
August 06-07, 2018

18th International Conference on Pediatrics Health

Madrid, Spain
July 16-18, 2018

World Congress on Green Chemistry and Green Engineering

Melbourne, Australia
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany

Glycans in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in